We are live on ! Find out more
FCM

Fourpath Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 29.98%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+29.98%
3 Year Est. Return
+72.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$2.97M
Cap. Flow
-$10.8M
Cap. Flow %
-7.46%
Top 10 Hldgs %
48.25%
Holding
148
New
12
Increased
38
Reduced
78
Closed
8

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$530K
2
FJUL icon
FT Vest US Equity Buffer ETF July
FJUL
+$508K
3
GILD icon
Gilead Sciences
GILD
+$351K
4
TGT icon
Target
TGT
+$267K
5
LLY icon
Eli Lilly
LLY
+$238K

Top Sells

Rank Stock Value
1
RWM icon
ProShares Short Russell2000
RWM
+$3.92M
2
SJB icon
ProShares Short High Yield
SJB
+$2.41M
3
SH icon
ProShares Short S&P500
SH
+$2.23M
4
GDX icon
VanEck Gold Miners ETF
GDX
+$1.35M
5
MDT icon
Medtronic
MDT
+$565K

Sector Composition

Rank Sector Weight
1 Energy 16.92%
2 Technology 8.48%
3 Financials 6.92%
4 Healthcare 6.43%
5 Consumer Staples 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSX icon
101
Phillips 66
PSX
$82.9B
$275K 0.19%
1,686
+8
+0.5% +$1.15K
ZTS icon
102
Zoetis
ZTS
$32.1B
$275K 0.19%
1,626
+487
+43% +$91.2K
ISRG icon
103
Intuitive Surgical
ISRG
$122B
$269K 0.19%
674
+24
+4% +$9.07K
ASML icon
104
ASML
ASML
$671B
$267K 0.19%
275
-2
-0.7% -$1.77K
MRK icon
105
Merck
MRK
$315B
$265K 0.18%
2,007
-4
-0.2% -$493
UBER icon
106
Uber
UBER
$147B
$265K 0.18%
3,440
-312
-8% -$22.4K
PANW icon
107
Palo Alto Networks
PANW
$292B
$265K 0.18%
1,864
-148
-7% -$23.3K
LLY icon
108
Eli Lilly
LLY
$1.05T
$260K 0.18%
+334
New +$238K
RTX icon
109
RTX Corp
RTX
$261B
$258K 0.18%
2,646
+146
+6% +$13.2K
ADBE icon
110
Adobe
ADBE
$94.3B
$252K 0.18%
500
-25
-5% -$14.3K
CCI icon
111
Crown Castle
CCI
$34.6B
$251K 0.17%
2,370
-2,313
-49% -$252K
ADI icon
112
Analog Devices
ADI
$183B
$251K 0.17%
1,268
+3
+0.2% +$577
COP icon
113
ConocoPhillips
COP
$140B
$250K 0.17%
1,960
+201
+11% +$22.9K
GM icon
114
General Motors
GM
$68.6B
$247K 0.17%
5,449
-667
-11% -$25.8K
XLRE icon
115
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.59B
$240K 0.17%
+6,076
New +$236K
VGSH icon
116
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$240K 0.17%
4,135
– –
NKE icon
117
Nike
NKE
$64.9B
$240K 0.17%
2,550
+3
+0.1% +$305
NOW icon
118
ServiceNow
NOW
$106B
$237K 0.16%
+1,555
New +$236K
TJX icon
119
TJX Companies
TJX
$171B
$237K 0.16%
2,336
+140
+6% +$13.6K
CRL icon
120
Charles River Laboratories
CRL
$10.8B
$235K 0.16%
868
-8
-0.9% -$1.91K
UL icon
121
Unilever
UL
$134B
$233K 0.16%
4,132
-2,495
-38% -$138K
SBUX icon
122
Starbucks
SBUX
$120B
$233K 0.16%
+2,545
New +$237K
LOW icon
123
Lowe's Companies
LOW
$117B
$232K 0.16%
912
+5
+0.6% +$1.15K
SRLN icon
124
State Street Blackstone Senior Loan ETF
SRLN
$5.31B
$229K 0.16%
+5,446
New +$228K
ABNB icon
125
Airbnb
ABNB
$86.6B
$228K 0.16%
+1,383
New +$209K
2 3 4
5
6

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $697M AUM 23.83% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
AIA
Allied Investment Advisors Billings, Montana $697M AUM 21.33% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return

Fourpath Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Fourpath Capital Management held 148 positions worth $144M, down 2% from $147M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Fourpath Capital Management withdrew a net $10.8M in Q1 2024, closing 8 positions and reducing 78 holdings. Its most notable exit was Medtronic, an estimated $565K position sold in full.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Fourpath Capital Management opened a new position in Bristol-Myers Squibb worth $564K.

  • Fourpath Capital Management's largest Q1 2024 buy was Bristol-Myers Squibb: 10,407 shares worth $564K.
  • Fourpath Capital Management added most to Gilead Sciences in Q1 2024, an estimated $351K increase.
  • Fourpath Capital Management's biggest Q1 2024 reduction was ProShares Short Russell2000, cutting an estimated $3.92M.
  • Fourpath Capital Management fully exited Medtronic in Q1 2024, selling an estimated $565K.
  • Fourpath Capital Management's ten largest holdings make up 48% of its $144M portfolio in Q1 2024.
  • Fourpath Capital Management opened 12 new positions and closed 8 in Q1 2024.
  • Fourpath Capital Management's portfolio value fell 2% quarter-over-quarter to $144M.

Based on Fourpath Capital Management's 13F filing for Q1 2024, filed 7 May 2024.